Manufacturer record

Bestcare Formulation Pvt: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Bestcare Formulation Pvt (Puducherry) were declared Not of Standard Quality between July 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: BGL260507, Ranitidine Oral Solution IP (exp Apr 2028). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content- Ranitidine in Ranitidine Hydrochloride. Listed in the September 2026 alert.

Records by type

4 records linked to Bestcare Formulation Pvt in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2026
4
Products affected
Other
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ranitidine Oral Solution IP Batch BGL260507Mfg May 2026 · Exp Apr 2028 content- Ranitidine in Ranitidine HydrochlorideOther Drug Testing Laboratory, Madurai-19State lab Sep 2026
Sucralate & Oxetacaine suspension Batch BGL250915Mfg Sep 2025 · Exp Aug 2027 Content - OxetacaineOther DTL, Madurai-19State lab Aug 2026
Betamethasone valerate & Salicylic Acid Ointment Batch BE533Mfg Jun 2025 · Exp May 2027 Content (Nil)Other Drug testing laboratory, Chennai-6State lab Jul 2026
Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Batch BGL250945Mfg Sep 2025 · Exp Aug 2027 Content of Ambroxol Hydrochloride(75.7%) and Terbutaline Sulphate (85.6%)Other Drugs Testing Laboratory, Chennai-06State lab Jul 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.